DCM Support: cell therapy and circulatory support for dilated cardiomyopathy patients with severe ventricular impairment

AIMS: The DCM Support trial (NCT03572660) uses a percutaneous circulatory support device (Impella CP, Abiomed, Danvers, MA, USA) to improve the safety of an intracoronary cell infusion procedure in patients with dilated cardiomyopathy (DCM) and a severely reduced left ventricular ejection fraction (...

Descripción completa

Detalles Bibliográficos
Autores principales: Reid, Alice, Hussain, Mohsin, Veerapen, Jessry, Ramaseshan, Rohini, Hall, Russell, Bowles, Ruth, Jones, Daniel A., Mathur, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Study Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375109/
https://www.ncbi.nlm.nih.gov/pubmed/37190883
http://dx.doi.org/10.1002/ehf2.14393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375109/
https://www.ncbi.nlm.nih.gov/pubmed/37190883
http://dx.doi.org/10.1002/ehf2.14393

Ejemplares similares